![Christine Silverstein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christine Silverstein
Director of Finance/CFO at
Artios Pharma Ltd.
Net worth: 767 588 $ as of 2026-07-30
Profile
Christine Berni Silverstein is currently Chief Financial Officer at Artios Pharma Ltd. since 2024.
Christine is also a member of the National Investor Relations Institute, Women in Bio, Inc., and Project 1972, Inc. Former roles include Managing Director at SCO Financial Group LLC; Director-Investor Relations at Relmada Therapeutics, Inc. from 2014 to 2016; Independent Director at Immedica Pharma US, Inc. from 2023 to 2025; Independent Director at Abeona Therapeutics, Inc. from 2020 to 2026; Chief Financial Officer at Excision BioTherapeutics, Inc. from 2021 to 2024; and Chief Financial Officer at Emendo Biotherapeutics, Inc. from 2020 to 2021.
Education includes undergraduate studies at Peter J.
Tobin College of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-14 | 119,562 ( 0.21% ) | 767 588 $ | 2026-07-30 |
Christine Silverstein active positions
| Companies | Position | Start |
|---|---|---|
National Investor Relations Institute
 National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services Operates as a association for corporate officers and investors | Corporate Officer/Principal | - |
Women in Bio, Inc.
 Women in Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a organization to help women entrepreneurs and executives | Corporate Officer/Principal | - |
Project 1972, Inc.
 Project 1972, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a women’s leadership network that promotes members to amplify their influence, access tools and connections | Corporate Officer/Principal | - |
Artios Pharma Ltd.
 Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for cancer treatment | Director of Finance/CFO | 2024-01-31 |
Former positions of Christine Silverstein
| Companies | Position | End |
|---|---|---|
| ABEONA THERAPEUTICS INC. | Director of Finance/CFO | 2020-03-30 |
| MARINUS PHARMACEUTICALS, INC. | Director/Board Member | 2025-02-10 |
Excision BioTherapeutics, Inc.
 Excision BioTherapeutics, Inc. BiotechnologyHealth Technology Develops gene editing therapeutics | Director of Finance/CFO | 2023-12-31 |
Emendo Biotherapeutics, Inc.
 Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Operates genome editing company that develops genetic medicines and cell therapies for severe diseases | Director of Finance/CFO | 2020-12-31 |
| RELMADA THERAPEUTICS, INC. | Investor Relations Contact | 2015-12-31 |
Training of Christine Silverstein
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
54
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Abeona Therapeutics, Inc.
 Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
Marinus Pharmaceuticals, Inc.
 Marinus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for rare genetic epilepsies and other seizure disorders | Health Technology |
SCO Financial Group LLC
 SCO Financial Group LLC Investment Banks/BrokersFinance Operates a full service merchant bank | Finance |
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services Operates as a association for corporate officers and investors | Commercial Services |
Women in Bio, Inc.
Women in Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a organization to help women entrepreneurs and executives | Commercial Services |
Relmada Therapeutics, Inc.
 Relmada Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products for the treatment of depression and other central nervous system diseases | Health Technology |
Peter J. Tobin College of Business
 Peter J. Tobin College of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for cancer treatment | Health Technology |
Excision BioTherapeutics, Inc.
Excision BioTherapeutics, Inc. BiotechnologyHealth Technology Develops gene editing therapeutics | Health Technology |
Project 1972, Inc.
Project 1972, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a women’s leadership network that promotes members to amplify their influence, access tools and connections | Commercial Services |
Emendo Biotherapeutics, Inc.
Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Operates genome editing company that develops genetic medicines and cell therapies for severe diseases | Health Technology |
- Stock Market
- Insiders
- Christine Silverstein
